Collaborators |
Detail Information
Publications
The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncologyAmy E McKee
U S Food and Drug Administration, Silver Spring, Maryland 20993, USA
Oncologist 15:13-8. 2010..Surrogate endpoints may be acceptable for "accelerated" approval, with a sponsor commitment to provide evidence of clinical benefit in a subsequent trial...
